Infant Mortality Rate (IMR)

The infant mortality rate (IMR) is a demographic indicator that measures the number of deaths of children under one year of age per 1,000 live births in a specified calendar year. Its conceptual foundation rests on the international statistical standard codified by the World Health Organization, which defines a "live birth" as the complete expulsion or extraction of a product of conception that, after separation, shows any sign of life—breathing, heartbeat, pulsation of the umbilical cord, or voluntary muscle movement—irrespective of gestational duration. The denominator is restricted to live births, which distinguishes the IMR from rates calculated against total population. In India the authoritative source is the Sample Registration System (SRS), a large-scale demographic survey operated by the Office of the Registrar General of India under the Ministry of Home Affairs, supplemented by the National Family Health Survey (NFHS) conducted under the Ministry of Health and Family Welfare. Globally, the indicator is tracked by the UN Inter-agency Group for Child Mortality Estimation (UN IGME) and embedded within Sustainable Development Goal 3 on health.

The calculation is procedurally direct. The numerator is the count of deaths among infants below 365 completed days of life during the reference year; the denominator is the total number of live births registered or estimated for that same year; the quotient is multiplied by 1,000 to express the result as a rate per thousand. Because vital registration is incomplete in many developing states, statisticians rarely derive the IMR by simple division of registered events. Instead they use indirect estimation techniques—most prominently the Brass method, which converts data on children ever born and children surviving (collected by maternal age cohort in censuses and surveys) into mortality probabilities. Model life tables then translate these probabilities into a standardized IMR, smoothing the distortions caused by under-registration of both births and infant deaths.

The IMR decomposes into two analytically distinct components. Neonatal mortality covers deaths within the first 28 completed days of life and is driven predominantly by endogenous causes—prematurity, low birth weight, birth asphyxia, congenital anomalies, and neonatal sepsis. Post-neonatal mortality spans the remaining period from 28 days to one year and is dominated by exogenous causes such as diarrhoeal disease, pneumonia, malnutrition, and inadequate sanitation. This partition carries policy weight: a high neonatal share signals deficits in obstetric and immediate newborn care, whereas a high post-neonatal share points to environmental, nutritional, and public-health failures. The IMR is therefore prized as a sensitive composite proxy for the overall health infrastructure, female literacy, water and sanitation access, and socioeconomic development of a population.

Contemporary figures illustrate the indicator's trajectory. India's IMR, recorded at roughly 129 per 1,000 around 1971, had fallen to 28 per 1,000 according to SRS 2020 data released by the Registrar General, with substantial interstate variation: Kerala reported single-digit figures near 6, while Madhya Pradesh remained above 40. The National Health Policy 2017 set a target of reducing the IMR to 28 by 2019, and the India Newborn Action Plan (INAP), launched in 2014 by the Ministry of Health and Family Welfare, set a "single-digit" neonatal mortality goal. Programmatic instruments include the Janani Suraksha Yojana cash-incentive scheme for institutional delivery, the Janani Shishu Suraksha Karyakram, and the Mission Indradhanush immunization drive launched in 2014.

The IMR must be distinguished from several adjacent measures. The under-five mortality rate (U5MR) counts deaths before the fifth birthday per 1,000 live births and is the SDG 3.2 headline child-survival indicator, capturing a broader span than the IMR. The perinatal mortality rate combines late foetal deaths (stillbirths) with early neonatal deaths and uses a denominator of total births including stillbirths. The maternal mortality ratio (MMR) measures maternal, not infant, deaths and is expressed per 100,000 live births. The crude death rate, by contrast, counts all deaths per 1,000 total population and is far less sensitive to development conditions. Confusing the IMR with the U5MR or the child mortality rate (deaths between ages one and five) is a common analytical error in policy briefs.

Edge cases and controversies persist. The treatment of extremely premature infants at the margin of viability affects cross-country comparability, because jurisdictions applying different gestational thresholds for recording a "live birth" versus a "stillbirth" produce non-comparable rates—a recurring caveat when comparing, for example, United States and European figures. Under-registration of female infant deaths in some South Asian contexts can mask sex-differential mortality. The COVID-19 pandemic disrupted both vital registration and routine immunization, and analysts continue to assess its effect on infant survival in 2020–2022. Methodological debate also surrounds the reliance on modelled estimates where civil registration and vital statistics (CRVS) systems remain weak.

For the working practitioner—the UPSC aspirant, the desk officer drafting a health brief, or the development analyst benchmarking states—the IMR remains an indispensable diagnostic. It is a leading entry in the GS Paper I demography syllabus and GS Paper II governance discussions on health-sector schemes. Because it responds to interventions in antenatal care, skilled birth attendance, breastfeeding promotion, immunization, and sanitation, it functions as both an outcome indicator and an evaluative yardstick for policy. Reading the IMR alongside its neonatal and post-neonatal components, and alongside the U5MR and MMR, allows a practitioner to locate precisely where a health system is failing its youngest citizens.